Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
January 10, 2023 10:15 ET
|
Silo Pharma, Inc.
Parkinson's disease, bipolar disorder, and chronic pain targeted in study Study aims to support psilocybin as a potential therapeutic for inflammatory disorders ENGLEWOOD CLIFFS,...
Behavioral Health Market to Cross Valuation of US$ 262 Bn by 2031; Growing Need for Treating Substance Abuse Disorders Underpins Abundant Avenues: TMR Study
June 06, 2022 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 06, 2022 (GLOBE NEWSWIRE) -- The global market study on behavioral health market is witnessing steady creation of lucrative opportunities on the back of...
Worldwide Bipolar Disorder Drugs and Treatment Industry to 2032 - by Drug Class and Region
June 03, 2022 06:18 ET
|
Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Global Bipolar Disorder Drugs and Treatment Market 2022-2032" report has been added to ResearchAndMarkets.com's offering. A recent market study...
Global Mental Wellness Markets, 2022-2027 - Data Analytics Increasingly Powering Wellness / Use of Technology to Improve Outcomes / Growing Reign of Artificial Intelligence
May 11, 2022 06:48 ET
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Mental Wellness Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global mental...
Bipolar Disorder Drugs and Treatment Market to Be Worth US$ 8.1 Billion by the Year 2032 - Comprehensive Research Report by FMI
March 22, 2022 10:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, March 22, 2022 (GLOBE NEWSWIRE) -- The global Bipolar Disorder Drugs And Treatment Market share, which was anticipated to be worth US$5.9 billion in 2022, is expected to...
Developing New Treatments for Mania Using Brain-Based Risk Markers - A Free Webinar from the Brain & Behavior Research Foundation
November 04, 2021 08:59 ET
|
Brain & Behavior Research Foundation
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Mania Using Brain-Based Risk Markers” on...
Former Duke Basketball Coach McCallie to Address FAU Students
July 15, 2021 09:02 ET
|
Florida Atlantic University College of Business
BOCA RATON Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Former Duke University women’s basketball coach Joanne P. McCallie, now an author and advocate for mental health awareness, will speak to students...
OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder
July 01, 2021 08:00 ET
|
OWP Pharmaceuticals, Inc.
NAPERVILLE, Ill., July 01, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Outlook on the Precision Psychiatry Global Market to 2026 - Increasing Adoption of Inorganic Growth Strategies is Driving Growth
April 09, 2021 07:58 ET
|
Research and Markets
Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Psychiatry Market: Focus on Product Type, Biomarker, Sample, Technology, Applications, End Users, Country Data (15 Countries), and...
Global Psychedelic Drugs Markets, 2018-2020 & 2021-2025 - Ketamine, Psilocybin, Ibogaine, LSD, Dimethyltryptamine (DMT), or MDMA
March 25, 2021 07:48 ET
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's...